Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM technology, and Bruker Corporation, one of the world's leading analytical instrumentation companies, have entered into a new partnership.
//
//
Medical Home
Life Sciences Home
Become a Member
Search
Medical Home
Life Sciences Home
About
News
Health A-Z
Drugs
Medical Devices
Interviews
White Papers
MediKnowledge
More...
Newsletters
Health & Personal Care
Twitter Channels
Contact
Meet the Team
Advertise
Search
Medical Home
Life Sciences Home
About
News
Life Sciences A-Z
White Papers
Lab Equipment
Interviews
Newsletters
Webinars
More...
Contact
Twitter Channels
Meet the Team
Advertise
Search
MediKnowledge
Newsletters
Health & Personal Care
Twitter Channels
Contact
Meet the Team
Advertise
Search
Webinars
Contact
Twitter Channels
Meet the Team
Advertise
Search
Menu
//
//
Cytosurge and Bruker partnership enables FluidFM single cell experiments on BioScope Resolve BioAFM
Download PDF CopyView Supplier Profile
July 2, 2018
Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, and Bruker Corporation, one of the world's leading analytical instrumentation companies, have entered into a new partnership.
Thanks to this Premium partnership, researchers can combine the femtoliters scale fluid control and cell treatment precision of FluidFM with the force control, resolution and speed available with Bruker’s exclusive PeakForce Tapping® technology.
Due to the new combination with Cytosurge’s FluidFM technology, the BioScope Resolve® BioAFM now becomes an even more powerful tool. The exclusive PeakForce QNM® and FastForce Volume™ capabilities of the BioScope Resolve combined with FluidFM technology opens a broad range of FluidFM applications for BioScope Resolve BioAFM users – from single cell adhesion and injection into single cells, through colloidal studies to nanolithography.
Dr. Pascal Behr, CEO of Cytosurge AG, is very pleased about the new Premium partnership:
Working together with Bruker as one of the world’s leading AFM providers marks an important milestone for Cytosurge. This new Premium partnership reinforces our vision of enabling the full potential of FluidFM technology for the benefit of researchers world-wide. We expect to see many exciting innovations and new applications when our technology is coupled with those of our partners. This new Premium collaboration with Bruker will enable us to deliver highly integrated and versatile FluidFM solutions based on Bruker’s state-of-the-art AFM product portfolio - starting today with the Bruker BioScope Resolve AFM."
Also David V. Rossi, Executive Vice President and General Manager of Bruker's AFM Business, is satisfied:
Partnering with Cytosurge to integrate FluidFM with BioScope Resolve and PeakForce Tapping technology fits perfectly with our strategy to take BioAFM experiments beyond imaging, from mechanobiology and drug delivery to the probing of biochemical interactions. Manipulating cells, and injecting biomolecules into cells while sensing piconewton forces, and imaging at the nanometer scale, are AFM capabilities that enable fundamentally new correlative information."
The Partnership with Bruker is the third of a series between Cytosurge and leading AFM manufacturers, designed to make FluidFM available to as many AFM users as possible. Dr. Michael Gabi, CTO of Cytosurge, describes the FluidFM AFM Partnership Program:
We work closely together with established AFM manufacturers to deliver high quality solutions and maximize customer value. Our unique program will allow new and existing AFM owners to leverage their AFM investments to their full potential."
Source:https://www.cytosurge.com/page/press-release-bruker-premium-partnership-english
Posted in: Business / Finance | Device / Technology News | Life Sciences News
Tags: Cell, Cell Adhesion, Drug Delivery, Nanotechnology
Comments (0)
Download PDF CopyView Supplier Profile
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
$(function() { BlogEngine.initComments(); });
Cancel reply to comment
$(function() { AZoProfileUtils.initAZoProfileIdentityBox(); });
Post a new comment
Login
(Logout)
Post
var currentCommentItemTypeId = 1;
var currentCommentItemId = 'e9060969-e5f5-4b00-9c67-1a491de9596b';
//
Advertisement
TrendingStories
LatestInterviews
Top Life Sciences Articles
Researchers identify new form of depressionScientists identify gene that triggers senescenceGenetic mutation shown to cause bipolar disorderArtificial Intelligence and Machine Learning in Medical ImagingFemale bladder bacteria found to be similar to microbes in the vagina
Achieving the WHO’s Global Action Plan for Dementia
Dr. Matthew Norton
One year on from the WHO's Global Action Plan for Dementia, Dr. Matthew Norton from Alzheimer's Research UK discusses the steps that have been taken so far, and whether we are likely to meet the 2025 target.
Studying The Effects of Microgravity on Muscle Mass
Professor Louis Yuge
Studying the effects of gravity on muscle cells can give us an insight into muscle wastage diseases, and potentially guide the development of new therapies. Professor Louis Yuge discusses his research and the cellular changes that occur in response to microgravity.
Investigating the Unique Nanomechanical Properties of Tooth Enamel
Dr Yeau-Ren Jeng
My background is in tribology, which is the science of the interactions between surfaces in relative motion. This involves looking at behaviour, such as friction, wear and lubrication, and the relationships between them.
CRISPR-Cpf1What are Plasmids?Melanin Production PathwayAnti-Counterfeiting Technology for Medical Devices
Latest Life Science NewsCytosurge and Bruker partnership enables FluidFM single cell experiments on BioScope Resolve BioAFMFirst state-of-the-art biofabrication hub opens at University of IllinoisNMR technique reveals the cause of synergistic toxicity in nanomaterialsDrinking alcohol alters adolescents’ metabolism and grey matter volumePittcon Exposition Committee opens 2019 booth space reservations
//
$(function () {
BlogEngine.initFixedPosition('#newsletter-content', '#newsletter-content-wrap', '.sidebar-container', 'main');
Azom.wireNewsletterPreviews();
});
Newsletters you may be interested in
Atomic Force Microscopy (AFM)
(Subscribe or Preview)
Biochemistry
(Subscribe or Preview)
Cell Biology
(Subscribe or Preview)
See all Newsletters »
Medical Links
Medical Home
News
Health A-Z
White Papers
Thought Leaders
Insights
MediKnowledge Series
Health & Personal Care
Medical Devices
Drugs
Life Sciences Links
Life Sciences Home
News
Lab Instruments & Equipment
Life Sciences A-Z
White Papers
Thought Leaders
Insights
Webinars
Other Useful Links
About
Meet the Team
Search
Newsletters
Twitter Channels
Sitemap
Advertise
Contact
Update Your Privacy Preferences
Terms & Conditions
Privacy & Cookie Policy
Facebook
Twitter
Google Plus
News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.
This site complies with the HONcode standard for trustworthy health information: verify here.
News-Medical.net - An AZoNetwork Site
Owned and operated by AZoNetwork, © 2000-2018
var _sf_async_config={};
/** CONFIGURATION START **/
_sf_async_config.uid = 17295;
_sf_async_config.domain = 'news-medical.net';
_sf_async_config.noCookies = true;
_sf_async_config.sections = 'Change this to your Section name'; //CHANGE THIS
_sf_async_config.authors = 'Change this to your Author name'; //CHANGE THIS
/** CONFIGURATION END **/
(function(){
function loadChartbeat() {
window._sf_endpt=(new Date()).getTime();
var e = document.createElement('script');
e.setAttribute('language', 'javascript');
e.setAttribute('type', 'text/javascript');
e.setAttribute('src',
(('https:' == document.location.protocol) ? 'https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/' : 'http://static.chartbeat.com/') +
'js/chartbeat.js');
document.body.appendChild(e);
}
var oldonload = window.onload;
window.onload = (typeof window.onload != 'function') ?
loadChartbeat : function() { oldonload(); loadChartbeat(); };
})();
//
// 0) {
// first ad
//document.write('');
//document.write('');
document.write('');
}
//]]>
//
// 0) {
document.write('Advertisement');
document.write('');
//document.write('